2024-03-01 2025-02-28 false Capium Accounts Production 1.1 12454780 2024-03-01 2025-02-28 12454780 bus:AbridgedAccounts 2024-03-01 2025-02-28 12454780 bus:FRS102 2024-03-01 2025-02-28 12454780 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 12454780 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12454780 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12454780 2024-03-01 2025-02-28 12454780 2025-02-28 12454780 bus:RegisteredOffice 2024-03-01 2025-02-28 12454780 core:WithinOneYear 2025-02-28 12454780 core:AfterOneYear 2025-02-28 12454780 1 2024-03-01 2025-02-28 12454780 bus:Director1 2024-03-01 2025-02-28 12454780 bus:Director1 2025-02-28 12454780 bus:Director1 2023-03-01 2024-02-29 12454780 bus:Director2 2024-03-01 2025-02-28 12454780 bus:Director2 2025-02-28 12454780 bus:Director2 2023-03-01 2024-02-29 12454780 2023-03-01 12454780 bus:LeadAgentIfApplicable 2024-03-01 2025-02-28 12454780 2023-03-01 2024-02-29 12454780 2024-02-29 12454780 core:WithinOneYear 2024-02-29 12454780 core:AfterOneYear 2024-02-29 12454780 bus:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 12454780 core:LandBuildings 2024-03-01 2025-02-28 12454780 core:LandBuildings 2025-02-28 12454780 core:LandBuildings 2024-02-29 12454780 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-02-28 12454780 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 12454780 core:NetGoodwill 2024-03-01 2025-02-28 12454780 core:NetGoodwill 2025-02-28 12454780 core:NetGoodwill 2024-02-29 12454780 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 12454780 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 12454780 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-02-28 12454780 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 12454780 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 12454780 core:Non-currentFinancialInstruments 2025-02-28 12454780 core:Non-currentFinancialInstruments 2024-02-29 12454780 core:ShareCapital 2025-02-28 12454780 core:ShareCapital 2024-02-29 12454780 core:RetainedEarningsAccumulatedLosses 2025-02-28 12454780 core:RetainedEarningsAccumulatedLosses 2024-02-29 12454780 dpl:Item1 2024-03-01 12454780 dpl:Item1 2025-02-28 12454780 dpl:Item1 2023-03-01 12454780 dpl:Item1 2024-02-29 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12454780
England and Wales

 

 

 

MAZIN HEALTHCARE LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 March 2024

End date: 28 February 2025
Accountant’s report
You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Myrtle Gund Ltd
28 February 2025



....................................................

Myrtle Gund Ltd

248 Lockwood Road

Huddersfield
HD1 3TG
04 December 2025
1
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Intangible fixed assets 3 85,000    90,000 
Tangible fixed assets 4 252,000    252,000 
337,000    342,000 
Current assets      
Stocks 16,400    16,400 
Debtors 82,142    68,526 
Cash at bank and in hand 12,596    27,462 
111,138    112,388 
Creditors: amount falling due within one year (119,758)   (123,097)
Net current assets (8,620)   (10,709)
 
Total assets less current liabilities 328,380    331,291 
Creditors: amount falling due after more than one year (240,665)   (275,585)
Net assets 87,715    55,706 
 

Capital and reserves
     
Called up share capital 150    150 
Profit and loss account 87,565    55,556 
Shareholders' funds 87,715    55,706 
 


For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 04 December 2025 and were signed on its behalf by:


-------------------------------
Noshad Akhtar
Director
2
General Information
MAZIN HEALTHCARE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12454780, registration address Sale Pharmacy, 2 Eastway , Sale, M33 4DX.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 3 (2024 : 3).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 March 2024 100,000    100,000 
Additions  
Disposals  
At 28 February 2025 100,000    100,000 
Amortisation
At 01 March 2024 10,000    10,000 
Charge for year 5,000    5,000 
On disposals  
At 28 February 2025 15,000    15,000 
Net book values
At 28 February 2025 85,000    85,000 
At 29 February 2024 90,000    90,000 


4.

Tangible fixed assets

Cost or valuation Land and Buildings   Total
  £   £
At 01 March 2024 252,000    252,000 
Additions  
Disposals  
At 28 February 2025 252,000    252,000 
Depreciation
At 01 March 2024  
Charge for year  
On disposals  
At 28 February 2025  
Net book values
Closing balance as at 28 February 2025 252,000    252,000 
Opening balance as at 01 March 2024 252,000    252,000 


3